Tisagenlecleucel for post-transplant relapse in young acute lymphoblastic leukemia patients: European real-world determinants of outcome
Laura M. Moser, Martin Hutter, Martina Ahlmann, Anna Alonso‐Saladrigues et autres
0 citationsLeukemia
Sara Ghorashian
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
128Publications signalées
4897Citations signalées
3Affiliations récentes
Institutions déclarées
Domaines associés
CAR-T cell therapy researchAcute Lymphoblastic Leukemia researchVirus-based gene therapy researchImmune Cell Function and InteractionViral Infectious Diseases and Gene Expression in Insects
Publications récentes
Overcoming the bottleneck: Use of the CD3Predict tool to streamline and improve access to chimeric antigen receptor T-cell leukapheresis
Maeve A O’Reilly, Aman Malhi, Gabriel Naylor-Leyland, Fady Samy et autres
0 citationsCytotherapy
Plasticity under pressure: biology and detection of lineage switch in acute leukemia
Alexandra E. Kovach, Yangyang Ding, Adam J. Lamble, Kathrin M. Bernt et autres
0 citationsLeukemia
Treatment of Pediatric Patients with Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia with Obecabtagene autoleucel, a CD19-Directed Chimeric Antigen Receptor T-cell Therapy: Preliminary Findings from the Phase Ib/II CATULUS Trial
Sara Ghorashian, Michael A Pulsipher, Juliana Silva, Alba Rubio-San-Simón et autres
0 citationsTransplantation and Cellular Therapy
The quintessential role for CAR T cell therapy in children, adolescents and young adults with cancer
Liora M. Schultz, Kevin O. McNerney, Adam J. Lamble, Friso Gerhard Jan Calkoen et autres
4 citationsNature Reviews Clinical Oncology
Maintenance after CAR T? Are we there yet? Reducing the risk of relapse after loss of anti-CD19 CAR T - cell persistence in ALL
Maria Gabelli, Sara Ghorashian
0 citationsHematology
Position statement from the British Society of Blood and Marrow Transplantation and Cellular Therapy on insertional oncogenesis in gene‐engineered advanced cell therapy products for treatment of haematological disorders
Sara Ghorashian, Robin Sanderson, Jungwha Lee, Amanda Black et autres
0 citationsBritish Journal of Haematology
Treatment of pediatric patients (pts) with relapsed/refractory B-cell acute lymphoblastic leukemia (R/R B-ALL) with obecabtagene autoleucel (obe-cel), a CD19-directed chimeric antigen receptor (CAR) T-cell therapy: Preliminary findings from the Phase Ib/II CATULUS trial
Sara Ghorashian, Michael A. Pulsipher, Juliana Silva, Alba Rubio‐San‐Simón et autres
0 citationsBlood
Harmonization on defining B‐cell recovery post CD19‐CAR T‐cell therapy in B‐cell acute lymphoblastic leukemia: An international consensus statement
Adam J. Lamble, Sandra D. Bohling, Kara L. Davis, Aimee C. Talleur et autres
7 citationsHemaSphere
SINGLE CENTRE EXPERIENCE IN TREATING PAEDIATRIC HIGH RISK (MYC REARRANGED OR HIGH STAGE) POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER (PTLD) USING INTERMEDIATE INTENSITY R-GRAB PROTOCOL
Rochana Redkar, Danny Cheng, Juliana Silva, Jack Bartram et autres
1 citationLeukemia Research
International consensus guidelines for the conduct and reporting of CAR T-cell clinical trials in AML
Swati Naik, Richard Aplenc, Susanne H.C. Baumeister, Marco Becilli et autres
8 citationsBlood Advances
CSF IL-6 in children with neuroinflammatory conditions
Valeria Pozzilli, Manori Prasadani Thambiliyagodage, Kshitij Mankad, Austen Worth et autres
2 citationsEuropean Journal of Paediatric Neurology
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.